Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02335944
Title Study of Safety and Efficacy of EGFR-TKI EGF816 in Combination With cMET Inhibitor INC280 in Adult Patients With EGFR Mutated Non Small Cell Lung Cancer.
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NOR | ITA | FRA | ESP | DEU | CAN | AUS

Facility Status City State Zip Country Details
Massachusetts General Hospital Mass General Boston Massachusetts 02114 United States Details
Novartis Investigative Site Melbourne Victoria 3000 Australia Details
Novartis Investigative Site Edmonton Alberta T6G 1Z2 Canada Details
Novartis Investigative Site Marseille Cedex 05 13885 France Details
Novartis Investigative Site Heidelberg Baden-Württemberg 69126 Germany Details
Novartis Investigative Site Koeln Nordrhein-Westfalen 50937 Germany Details
Novartis Investigative Site Bologna BO 40138 Italy Details
Novartis Investigative Site Modena MO 41124 Italy Details
Novartis Investigative Site Perugia PG 06129 Italy Details
Novartis Investigative Site Seoul Korea 05505 Korea, Republic of Details
Novartis Investigative Site Oslo NO 0424 Norway Details
Novartis Investigative Site Singapore 119228 Singapore Details
Novartis Investigative Site Singapore 168583 Singapore Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site La Coruna Galicia 15006 Spain Details
Novartis Investigative Site Las Palmas De Gran Canarias Las Palmas De Gran Canaria 35016 Spain Details
Novartis Investigative Site Madrid 28009 Spain Details
Novartis Investigative Site Madrid 28041 Spain Details
Novartis Investigative Site Taipei Taiwan ROC 10041 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field